Allerphast

Quick links to important sections

Allerphast

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Allerphast

Property Description
Active ingredient Fexofenadine hydrochloride
Form Film-coated tablet, oral suspension
Pharmacological class Second-generation antihistamine (H1 antagonist)
General purpose Relief from allergic sensitivity symptoms
Origin Synthetic, Piperidine derivative

Allerphast: Classification and Core Identity

Allerphast is a single-ingredient pharmaceutical preparation classified as a selective H1-receptor antagonist and a second-generation antihistamine, a category clinically recognized for systemic action in managing allergic conditions. Its core identity is defined by the active ingredient, Fexofenadine hydrochloride, which is a synthetic compound derived from the piperidine chemical structure. Fexofenadine's primary role is related to the histamine receptor system. Allerphast is designed for administration via the oral route, often positioned for both adults and children, and is typically available as a film-coated tablet and an oral suspension. The composition involves the active substance combined with necessary solid pharmaceutical excipients or an aqueous vehicle, depending on the final form.

Understanding its General Purpose and Action

The general purpose of Allerphast is to provide systemic relief by interrupting the physiological processes that cause allergy symptoms, representing a typical use scenario for mitigating symptoms of allergic rhinitis or chronic spontaneous urticaria. This therapeutic objective is achieved through targeted peripheral H1 receptor blockade, meaning the drug selectively prevents histamine from binding to its target receptors on cells. A defining characteristic of Fexofenadine is its property as a non-sedating antihistamine, as the molecule exhibits minimal central nervous system effects. This allows for relief while minimizing disruption to cognitive function. This feature is directly linked to its negligible non-penetration of the blood-brain barrier (BBB), a molecular distinction that ensures the blockade of the histamine effect is primarily localized to the periphery.

Regulatory References

  1. NIH - MedlinePlus

What side effects are possible with Allerphast?

Possible Side Effects and Safety Information

The official safety information for Allerphast is documented by government regulatory agencies and outlines the potential adverse reactions and restrictions associated with its use.

Common Adverse Reactions

Adverse reactions reported most often in clinical studies (classified as Common or occurring in more than 1 in 100 people) include:

  • Headache
  • Drowsiness
  • Dizziness
  • Nausea

These effects primarily involve the nervous system and gastrointestinal system.

Serious and Rare Adverse Reactions

Rare, but serious, adverse reactions have been documented primarily from postmarketing reports. These require particular attention and include systemic hypersensitivity reactions and cardiovascular issues:

  • Anaphylaxis (severe, whole-body allergic reaction)
  • Angioedema (swelling of the face, lips, tongue, and/or throat)
  • Serious Heart Rhythm Disturbances (irregular or fast heartbeat)
  • Liver Injury (e.g., yellowing of the skin or eyes)

Safety Restrictions and Considerations

Official regulatory documents establish specific safety restrictions:

  • Contraindication: Allerphast is not to be used by patients with a known hypersensitivity or allergy to the active substance or any of the inactive ingredients.
  • Population-Specific Caution: Caution is required for elderly patients and individuals with impaired kidney function, as the medicine may remain in the body longer, potentially requiring a modification to the amount taken.
  • Drug-Food Interactions: Taking this medicine with antacids containing aluminum or magnesium, or with certain fruit juices (grapefruit, apple, or orange), can reduce the amount of the medicine absorbed by the body. Concomitant use with certain antibiotics may also increase the concentration of Allerphast in the body.

Overdose and Emergency Response

Overdose and When to Seek Help

Allerphast (a non-sedating antihistamine) is generally associated with a low risk of severe toxicity in overdose compared to first-generation antihistamines. However, taking more than the recommended dosage can lead to an overdose and must be treated as an emergency.

Overdose symptoms reported in clinical and regulatory contexts can include effects on the central nervous system, such as dizziness or drowsiness. Other physical manifestations may include dry mouth and headache.

Overdose risk is directly linked to exceeding the directed dose, as specified on the product labeling. Consumers are strictly cautioned: Do not take more than directed.

Overdose Presentation (Common) Primary Emergency Action Required
Dizziness, Drowsiness, Dry Mouth Immediately seek professional medical attention

Urgent medical attention is required for any suspected overdose. In the event of an overdose, a person must get medical help or contact a Poison Control Center right away. Immediate emergency services should be called if the individual has collapsed, experienced a seizure, or has difficulty breathing. All medications, including this one, must be kept out of reach of children to prevent accidental poisoning.

Therapeutic Uses of Allerphast

What Allerphast Treats: Main Uses and Benefits

Allerphast is generally applied for symptomatic relief in conditions characterized by periods of heightened symptoms related to allergic sensitivity, and is relevant across therapeutic domains where additional symptomatic support is needed. The medication is commonly used to help manage symptoms that interfere with daily functioning, such as seasonal allergic rhinitis (Hay Fever) and the skin discomfort of chronic spontaneous urticaria (hives).

Use of the medication during phases when symptoms become more noticeable is considered relevant for addressing this discomfort. This is relevant for managing symptom clusters that may become intense or disruptive, including symptoms related to physical discomfort like sneezing, rhinorrhea, or itching and wheals. It contributes to improved comfort during periods of heightened symptoms and may assist with maintaining a sense of stability when symptoms are more noticeable.

Quick Facts

Quick Fact: Conditions and Symptoms
Applied in addressing symptoms of seasonal allergic rhinitis (Hay Fever).
Helps manage symptoms related to physical discomfort like pruritus and wheals (hives).
Supports general well-being during symptomatic phases.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Allerphast (a second-generation antihistamine, typically fexofenadine or cetirizine) is generally used by adults and children above a certain age, which varies depending on the specific active ingredient and the condition being treated (e.g., usually 6 months to 2 years for some uses, or 6 years and older for over-the-counter tablets).


Contraindications and Precautions

Individuals who should not use Allerphast include those with a known allergy or hypersensitivity to the active substance (fexofenadine or cetirizine) or any component of the formulation.

Caution and dose adjustment are necessary for patients with impaired kidney function (renal impairment) as the drug is primarily eliminated unchanged by the kidneys. Individuals with liver disease (hepatic impairment) may also require a lower dose, particularly with cetirizine.

  • Pregnancy and Breastfeeding: While antihistamines are often considered acceptable during pregnancy, use should only occur if clearly needed, and other agents with more extensive data may be preferred. The use of Allerphast is not generally recommended while breastfeeding as it can be excreted in breast milk and may potentially cause side effects in the infant.
  • Other Conditions: Use with caution in patients with conditions that increase the risk of seizures (such as epilepsy), or those with a predisposition to urinary retention.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Allerphast is involved in documented interactions with certain medicinal products and foods that can alter the concentration of the drug in the body. These constraints are based on effects on drug transport systems, specifically the Organic Anion Transporting Polypeptide (OATP) and P-glycoprotein (P-gp) transporters.

Interacting Agents Official Regulatory Constraint
Aluminum and Magnesium Hydroxide-Containing Antacids Do not take closely in time. Antacids reduce Allerphast absorption. The recommended separation time is at least 15 minutes.
Erythromycin and Ketoconazole Coadministration results in significantly increased Allerphast plasma concentrations, which is attributed to the agents’ influence on drug transport via P-gp and OATP. No differences in adverse events have been observed in studies.
Fruit Juices (Grapefruit, Orange, Apple) Consumption of these juices decreases the bioavailability of the medicine, which may reduce its overall effect. Allerphast should be taken with water, and not with fruit juices.

In addition to these specific drug and food interactions, official labeling includes a precaution for patients with renal impairment. Because the drug is mainly eliminated via the kidneys, its effects may be increased in patients with reduced kidney function.

Mechanism of Action

Peripheral H1 Receptor Inverse Agonism

The drug’s action involves functioning as a selective inverse agonist at the peripheral Histamine H1 receptor. Binding to the target stabilizes its inactive state, which suppresses the G q protein signaling cascade initiated by endogenous histamine. This molecular event prevents the full signal transduction that otherwise leads to increased vascular permeability and sensory nerve activation.

Functional Peripheral Selectivity

The drug's mechanism is characterized by its limited capacity to cross the blood-brain barrier (BBB), as it acts as a substrate for the P-glycoprotein (P-gp) efflux transporter. This active transport mechanism confines the drug primarily to the peripheral nervous and vascular systems. This restriction limits the drug's action to peripheral histamine pathways and is associated with minimal H1 receptor occupancy in the central nervous system.

Mechanism-to-Physiological Effect Cascade

Localized H1 receptor blockade modifies the physiological output of histamine-driven responses in the skin and vasculature. The interference with the molecular cascade is associated with reduced histamine-mediated fluid extravasation from capillaries and decreased stimulation of peripheral sensory nerve endings. These are the direct physiological consequences that underlie the drug's action profile.

Dosage and Administration Information

Official Dosing and Administration for Allerphast (Fexofenadine HCl)

The following information details the administration of the active ingredient, Fexofenadine hydrochloride.

Age Group Recommended Dosage Frequency
Adults and Children ge 12 Years 180 mg Once Daily (qDay)
Adults and Children ge 12 Years 60 mg Twice Daily (BID)
Children 6 to 11 Years 30 mg Twice Daily (BID)

Administration Method and Special Conditions

The medicine is administered orally (by mouth) and must be taken using water only.

  • Juice Restriction: Do not take the medicine with fruit juices, including grapefruit, orange, or apple juice, as this may interfere with how the medicine is absorbed.
  • Antacid Separation: Do not take aluminum- or magnesium-containing antacids at the same time as this medicine. A time separation of at least two hours is advised to prevent reduced absorption.
  • Renal Impairment: For patients 12 years and older with decreased kidney function, the starting dose should be reduced to 60 mg once daily. For children 6 to 11 years with decreased kidney function, the starting dose should be 30 mg once daily.

Missed Dose Rule

If a dose is missed, take the forgotten dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped entirely. Do not take a double dose to make up for a missed one.

These instructions define the dosing and administration protocol for this medicine.

Recent Clinical Evidence

Allerphast: Recent Clinical Evidence

Allerphast (fexofenadine) is classified as a second-generation H1 antagonist used for the management of symptoms associated with allergic conditions. Clinical investigation has focused extensively on its profile for treating seasonal allergic rhinitis (hay fever) and chronic idiopathic urticaria (hives).

Efficacy in Allergic Rhinitis

Multiple randomized, double-blind, placebo-controlled trials have studied the use of Allerphast. In a recent meta-analysis that included several thousand participants with allergic rhinitis, a statistically significant reduction in the Total Symptom Score (TSS) was observed in those receiving Allerphast compared to the placebo group. Specific symptoms evaluated in these studies included sneezing, runny nose (rhinorrhea), and itchy, watery, or red eyes.

Evidence suggests that the effect on symptoms may begin within a few hours of administration and can last for approximately 24 hours, supporting its use as a once- or twice-daily medication.

Profile in Urticaria

For chronic idiopathic urticaria, clinical data indicates that Allerphast may help relieve pruritus (itching) and reduce the number and size of hives. This finding aligns with its mechanism of action, which involves blocking the effects of histamine in the body.

Safety and Comparison

Studies generally indicate that Allerphast is associated with a favorable side effect profile when compared to first-generation antihistamines. Second-generation compounds, including Allerphast, cross the blood-brain barrier to a lesser extent, which is associated with a lower potential for sedation. Common reported adverse events in clinical trials were generally comparable to placebo and included occurrences of headache, nausea, and dizziness. The long-term use of Allerphast has been studied and has not been consistently linked to issues such as tachyphylaxis (reduced response over time).

Condition Studied Primary Endpoint Observation
Seasonal Allergic Rhinitis Statistically significant reduction in Total Symptom Score (TSS) vs. placebo.
Chronic Idiopathic Urticaria Observed reduction in pruritus and size/number of hives.

Frequently Asked Questions (FAQ)

Common questions about Allerphast (FAQ)

Q: What is the main purpose of Allerphast, according to official regulatory information?

Official product information states that the medicine is approved to help relieve the symptoms of seasonal allergic rhinitis, also known as hay fever. It is also approved for the treatment of symptoms related to chronic idiopathic urticaria (hives). These indications reflect the drug's primary regulatory uses.

Q: Is Allerphast considered a first-generation or second-generation type of medicine?

The active ingredient in Allerphast is generally classified in medical literature as a second-generation H1 antihistamine. This classification is based on its chemical structure and pharmacological profile, distinguishing it from first-generation antihistamines.

Q: Is the active ingredient in Allerphast available as a generic version?

Yes, the active ingredient, Fexofenadine, is available in both generic forms and under various brand names, depending on the region. This is common practice once a drug's original patent expires.

Q: What is the main difference between Allerphast and other popular allergy medicines like Zyrtec or Claritin?

The main difference lies in the specific chemical structure and pharmacological profile of the active ingredients. While all belong to the same pharmacological class, they each have distinct pharmacological profiles, which may include differing potential for central nervous system effects or specific interactions.

Q: How is Allerphast different from a nasal spray or a decongestant product?

Allerphast is an oral tablet that works systemically, meaning it affects histamine receptors throughout the body. In contrast, nasal sprays and decongestants usually work locally to narrow blood vessels in the nasal passages.

Q: Is Allerphast a prescription-only medicine, or can it be bought over the counter?

The availability depends on the specific dosage strength and the country's regulations. In many regions, certain common strengths are available for purchase over the counter. However, other strengths or specific formulations may require a prescription.

Q: Does Allerphast only help with allergy symptoms that are caused by histamine?

Yes, the medication works by selectively blocking the effects of histamine, which is a substance produced by the body that triggers many allergy symptoms. This specific function is defined in the official product information.

Q: What are the other uses of Allerphast beyond treating seasonal allergy symptoms?

Official documents confirm that the drug is also approved to help relieve the symptoms of chronic idiopathic urticaria, which is another name for chronic hives.

Q: How quickly does Allerphast start working after a person takes it?

Clinical data in official documents indicates that the onset of relief for allergic rhinitis symptoms is generally observed within approximately two hours of taking the medicine. This may vary slightly depending on the individual.

Q: What is the typical duration of effect for one dose of Allerphast?

Studies have shown the drug has a long duration of action. The official dosing schedule is based on this, with the drug being suitable for either a once-daily or twice-daily schedule, depending on the formulation and prescribed amount.

Q: Is it necessary to take Allerphast at the exact same time every day?

Official instructions advise taking the drug at around the same time or times every day to maintain a consistent level in the body. This consistent schedule is generally advised because waiting too long between doses may allow allergy symptoms to return.

Q: Does taking Allerphast before allergy symptoms appear make it work better?

Official guidance indicates that patients may continue taking the drug even during symptom-free periods to help maintain control over the underlying condition. Consistent use can help prevent the severity of symptoms when exposure occurs.

Q: Is Allerphast considered a medication that is appropriate for long-term daily use?

The duration of treatment is guided by the specific condition being treated. Clinical trials have examined the use of the drug for periods up to a year in some patient populations. Long-term use should be discussed with a healthcare provider.

Q: Can a person stop taking Allerphast as soon as their symptoms have disappeared?

Official guidance indicates that continued use is often necessary, even if symptoms have disappeared, as the medication controls symptoms but does not cure the underlying condition. Discontinuing the medicine may allow the symptoms to return.

Q: Is drowsiness a common side effect described in the official documents for Allerphast?

The medicine is generally classified as a non-drowsy antihistamine, meaning it is less likely to cause sleepiness than older drugs. However, official documents list drowsiness, tiredness, and headache as common side effects that can still occur in some individuals.

Q: Does Allerphast cause any of the less common side effects like dry mouth or dizziness?

Official documents list several less common side effects. These include dizziness, as well as reports of nausea or indigestion. The full list of potential side effects is detailed in the official safety information.

Q: Has Allerphast been associated with reports of changes in mood or anxiety?

Official adverse event reporting has included rare side effects such as nervousness. There have also been occasional reports of agitation or anxiety associated with the drug's use.

Q: Is it true that Allerphast can cause trouble sleeping for some individuals?

Official safety reporting notes that insomnia (sleeplessness) and general trouble sleeping are described as rare side effects.

Q: What should be expected if someone accidentally takes more Allerphast than the amount described on the label?

Clinical studies have shown that high single doses of the active ingredient were administered to healthy volunteers without the development of clinically significant adverse reactions. It is important to follow the labeled instructions carefully for appropriate use.

Q: Can Allerphast cause an allergic reaction itself, even though it treats allergies?

Yes, like most medicines, it is possible for a person to experience a serious allergic reaction to Allerphast itself. Official product information notes that if signs of a serious allergic reaction, such as hives, rash, swelling, or difficulty breathing, occur, medical attention should be sought immediately.

Q: Is the tiredness side effect from Allerphast the same as the sleepiness from older allergy medications?

The tiredness experienced with Allerphast is generally considered to be less frequent or less intense than the sleepiness associated with older, first-generation antihistamines. This is because Allerphast is a second-generation drug with limited capacity to cross the blood-brain barrier.

Q: Are there any reported effects of Allerphast on heart rhythm or blood pressure?

Clinical data has shown that the drug does not cause clinically significant changes to heart rhythm at approved dosages. The product information indicates it is not associated with QTc interval prolongation, a measure of heart electrical activity.

Q: Are there known interactions between Allerphast and alcohol consumption?

Official sources indicate that it is usually advised to avoid drinking alcohol while taking the medicine. Alcohol consumption is known to potentially increase the feeling of sleepiness or drowsiness that can be experienced with the drug.

Q: Can Allerphast be taken at the same time as common cold and flu medicines?

Regulatory warnings state that taking Allerphast with any other medicine that causes drowsiness may increase the feeling of sleepiness. The risk of side effects like dry mouth or difficulty with urination may also be worsened by certain combination products.

Q: Can Allerphast affect the effectiveness of birth control pills?

Official interaction checks conducted for the drug and common oral contraceptives found no clinically significant interaction. Therefore, the effectiveness of birth control pills is not expected to be reduced by taking Allerphast.

Q: Does Allerphast interact with common herbal supplements like St. John's Wort?

Clinical studies indicate that certain herbal supplements, such as St. John's Wort, may interact with the drug. The research shows these supplements can affect the drug's plasma concentration by altering transporter systems in the body.

Q: Can Allerphast be used by people who have a history of heart conditions or irregular heartbeat?

Clinical data shows the drug does not cause clinically significant changes to heart rhythm at approved doses. However, official information suggests that individuals with pre-existing heart conditions should review their use of this, or any, medication with a healthcare provider.

Q: Is Allerphast described as suitable for use in children under the age of 12?

The drug is approved and dosed for children in the 6 to 11 years age group. For children under 6 years, the official product information states that efficacy has not been established in all areas, and their use and dose must be determined by a doctor.

Q: Is Allerphast usage described in official documents for women who are pregnant or breastfeeding?

Official documentation indicates that information regarding the use of the drug during pregnancy is limited. Therefore, its use is usually reserved for cases where the benefit justifies the potential risk. For breastfeeding, only small amounts are known to pass into breast milk, and official information should be reviewed for guidance on specific circumstances.

Q: Is Allerphast known to affect the results of standard allergy skin prick tests?

Yes, Allerphast, as an antihistamine, is known to affect the results of standard allergy skin prick tests. Official guidance typically advises a washout period before undergoing such testing to avoid interference.

Q: Can older adults or seniors take the standard amount of Allerphast?

Studies have not demonstrated specific problems limiting the drug’s usefulness for the general elderly population. However, because age-related decreased kidney function is common, a dose adjustment may be appropriate if a person has known renal impairment.

Q: Does Allerphast contain ingredients that are known to be common allergens, such as lactose or dyes?

Official information notes that the inactive ingredients can vary by formulation. For example, some orally disintegrating tablets contain aspartame, which is relevant for individuals with phenylketonuria ( PKU). The specific inactive ingredients are listed on the package insert.

Q: What kind of evidence is available about the long-term effectiveness of Allerphast?

Clinical trials detailed in regulatory documents have demonstrated the drug's effectiveness in reducing the symptoms of seasonal allergic rhinitis and chronic idiopathic urticaria. These studies have examined its effects for periods of up to one year in certain patient groups.

Q: Are there clinical trials comparing the use of Allerphast in children versus in adults?

Yes, clinical trial data is available comparing the use in children and adults. The data shows that the drug's effects on histamine-induced symptoms in children aged 6–11 years are comparable to those observed in adults at similar concentrations in the blood.

Q: Is Allerphast officially approved for treating chronic hives (urticaria)?

Yes, the drug is officially approved for the treatment of chronic idiopathic urticaria, which is another name for chronic hives. This is in addition to its use for seasonal allergic rhinitis.

Q: Does the official documentation list a risk of dependency or abuse for Allerphast?

Studies performed following the drug's transition to over-the-counter status indicated a negligible impact on adverse event reporting related to misuse or abuse. This suggests the official documentation supports a low risk of dependency or abuse.

How should Allerphast be stored and disposed of?

How to Store and Dispose of Allerphast?

The official labeling mandates specific conditions to preserve product quality and safety.

Storage Requirements

Allerphast must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F), while protecting it from excess heat and moisture. The medication must be kept in the tightly closed, original container to maintain packaging integrity. For safety, the product must be stored out of the sight and reach of children, as explicitly required by regulatory authorities.

Disposal Instructions

Unused or expired Allerphast must be disposed of according to official guidelines. It is mandatory not to flush the medicine down the toilet or sink. The preferred disposal method is using a drug take-back program. If a program is unavailable, the product should be mixed with an unappealing substance, placed in a sealed bag, and discarded in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Allerphast found in:

A-Z Index: